Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study

Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study

Early management of spasticity may improve stroke outcome. Botulinum toxin type A (BoNT-A) is recommended treatment for post-stroke spasticity (PSS). However, it is usually administered in the chronic phase of stroke. Our aim was to determine whether the length of time between stroke onset and initi...

Full description

Bibliographic Details
Main Authors: Alessandro Picelli, Andrea Santamato, Michela Cosma, Alessio Baricich, Carmelo Chisari, Marzia Millevolte, Cristina Del Prete, Ilenia Mazzù, Paolo Girardi, Nicola Smania
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Toxins
Subjects:
botulinum toxins
muscle spasticity
rehabilitation
stroke
therapeutics
Online Access:https://www.mdpi.com/2072-6651/13/6/374

Internet

https://www.mdpi.com/2072-6651/13/6/374

Similar Items